Sponsors (4)
The bill strengthens U.S. tools and targeted reporting to disrupt foreign-linked fentanyl and methamphetamine supply chains and freeze illicit finance, but does so at the cost of increased diplomatic and economic risk, reduced transparency, and legal/administrative uncertainties for businesses and agencies.
Law enforcement, border communities, and federal policymakers will receive coordinated assessments and plans to disrupt PRC-linked fentanyl precursor supply chains, improving targeting of enforcement and international cooperation.
U.S. authorities (Treasury, State, DOJ, DEA) will have faster and clearer sanctions and designation tools to freeze assets and sanction foreign facilitators — including for single significant transactions — enabling quicker disruption of illicit finance tied to opioid trafficking.
Congress, the President, and federal agencies will get more specific, time‑bound reporting (including defined PRC-person scope and annual identification of major methamphetamine source countries) and near-term classified/unclassified briefings to inform oversight and policy decisions.
U.S.-China diplomatic and trade relations could be strained if the bill prioritizes PRC-linked designations and sanctions, risking retaliation that could harm U.S. businesses, supply chains, and taxpayers.
Changing or broadening the chemical/precursor language (removing specific references like pseudoephedrine) may create legal ambiguity about which substances are covered, weakening transparency and complicating enforcement oversight.
Permitting asset freezes or sanctions based on single transactions and knowledge-based standards increases legal uncertainty and compliance burdens for banks and companies, risking sudden business disruptions and higher costs for the financial sector.
Based on analysis of 7 sections of legislative text.
Expands U.S. reporting and sanctions to target foreign persons, entities, and government actors tied to fentanyl, precursors, and related financial activity and adjusts report deadlines.
Introduced March 5, 2025 by James Risch · Last progress March 5, 2025
Creates new reporting and sanctions tools to more aggressively target people, companies, government entities, and financial actors tied to fentanyl, fentanyl precursors, and related money flows—with special focus on shipments originating from the People’s Republic of China. It changes timing and content requirements for existing U.S. narcotics and methamphetamine source-country reports, requires new unclassified reports (with a classified annex) and briefings to Congress within 180 days, and broadens the Fentanyl Sanctions Act to allow sanctions on single significant transactions, recipients of illicit proceeds, facilitators, government-owned banks, and senior foreign officials. Implements definitional and deadline changes (including moving an annual report deadline from March 1 to June 1 and setting an explicit December 31, 2030 reference), expands the universe of sanctionable conduct and actors (including political subdivisions and government-controlled entities), and directs the Executive Branch to prioritize identifying PRC-linked persons and entities until the PRC is no longer the primary source of fentanyl shipments into the United States.